Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial

Shi, TY; Zhu, JQ; Feng, YL; Tu, DS; Zhang, YQ; Zhang, P; Jia, HX; Huang, X; Cai, YL; Yin, S; Jiang, R; Tian, WJ; Gao, W; Liu, JH; Yang, HJ; Cheng, X; Zang, RY

Zang, RY (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Gynaecol Oncol, Ovarian Canc Program, Shanghai 200032, Peoples R China.

LANCET ONCOLOGY, 2021; 22 (4): 439

Abstract

Background The benefits of secondary cytoreduction for platinum-sensitive relapsed ovarian cancer are still widely debated. We aimed to assess the eff......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索